It is not intended for human consumption or for use in the diagnosis, treatment, cure, or prevention of any disease

Wegovy, as an injection, is FDA approved to: Reduce excess body weight and maintain long-term weight reduction in: Adults with obesity and adolescents ages 12 years and older with obesity Adults with overweight plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol Treat a serious type of fatty liver disease called noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver scarring (stage F2 to F3 fibrosis) Lower the risk of major cardiovascular problems (such as heart attack, stroke, and heart-related death) in adults with established cardiovascular disease and obesity or overweight Contrave is FDA approved to: Reduce excess body weight and maintain long-term weight reduction in: Adults with obesity, defined as a body mass index (BMI) of 30 or higher Adults with a BMI of 27 or higher (overweight) plus at least one weight-related medical condition To recap, heres an at-a-glance comparison of FDA-approved uses for Wegovy vs

Many of them create special concerns for nutritionists, while others may primarily be managed with dietary approaches
[46] This complements Pre Lean's thermogenic goals by helping optimize fat utilization during workouts
Tirzepatide is a newer synthetic peptide that binds two incretin receptors at once: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
Abcam, MA, USA), anti-FOXA1 (ab23738